Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Inventory (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 1 years of Change in Inventory data on record, last reported at $2.0 million in Q4 2024.

  • For Q4 2024, Change in Inventory changed N/A year-over-year to $2.0 million; the TTM value through Dec 2024 reached $43.0 million, changed N/A, while the annual FY2024 figure was $43.0 million, 616.67% up from the prior year.
  • Change in Inventory reached $2.0 million in Q4 2024 per INDV's latest filing, down from $6.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $27.0 million in Q1 2024 and bottomed at $2.0 million in Q4 2024.